Target Information
Target General Infomation | |||||
---|---|---|---|---|---|
Target ID |
T71398
|
||||
Former ID |
TTDS00443
|
||||
Target Name |
Guanylate cyclase
|
||||
Synonyms |
Guanylyl Cyclase
|
||||
Target Type |
Successful
|
||||
Disease | Angina pectoris; Anal fissure [ICD9: 413, 565.0; ICD10: I20, K60.0-K60.2] | ||||
Angina pectoris [ICD9: 413; ICD10: I20] | |||||
Cancer [ICD9: 140-229; ICD10: C00-C96] | |||||
Hydrocephalus; Glaucoma [ICD10: H40-H42] | |||||
Respiratory failure [ICD9: 518.81; ICD10: J96] | |||||
BioChemical Class |
Phosphorus-oxygen lyases
|
||||
Target Validation |
T71398
|
||||
Drugs and Mode of Action | |||||
Drug(s) | Erythrityl Tetranitrate | Drug Info | Approved | Angina pectoris | [550675] |
Isosorbide Dinitrate | Drug Info | Approved | Angina pectoris; Anal fissure | [538159], [542062] | |
Isosorbide Mononitrate | Drug Info | Approved | Hydrocephalus; Glaucoma | [551871] | |
Methylene blue | Drug Info | Approved | Acquired methemoglobinemia | [538085] | |
Nitric Oxide | Drug Info | Approved | Respiratory failure | [536500], [539631] | |
Nitric Oxide | Drug Info | Phase 3 | Cancer | [539631], [551871] | |
Pirsidomine | Drug Info | Phase 2 | Angina pectoris | [544801] | |
References | |||||
Ref 536500 | Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome. Expert Opin Emerg Drugs. 2007 Sep;12(3):461-77. | ||||
Ref 538085 | Recombinant Plasmodium falciparum glutathione reductase is inhibited by the antimalarial dye methylene blue. FEBS Lett. 1998 Feb 6;422(3):311-4. | ||||
Ref 538159 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 040009. | ||||
Ref 539631 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2509). | ||||
Ref 542062 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7051). | ||||
Ref 534667 | Activation of soluble guanylyl cyclase by the nitrovasodilator 3-morpholinosydnonimine involves formation of S-nitrosoglutathione. Mol Pharmacol. 1998 Jul;54(1):207-12. | ||||
Ref 534837 | Nitric oxide modulation of the growth hormone-releasing activity of Hexarelin in young and old dogs. Metabolism. 1999 Feb;48(2):176-82. | ||||
Ref 536948 | Cervical priming in the first trimester: morphological and biochemical effects of misoprostol and isosorbide mononitrate. Acta Obstet Gynecol Scand. 2009;88(1):43-51. | ||||
Ref 537384 | Curcumin ameliorates high glucose-induced acute vascular endothelial dysfunction in rat thoracic aorta. Clin Exp Pharmacol Physiol. 2009 May 19. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.